Adverum Biotechnologies Inc (ADVM)
3.62
-0.19 -4.99%
NASDAQ
Feb 19, 13:52
Delayed 2m
USD
View All Key Stats
ADVM Key Stats
| Income Statement | |
| Revenue (TTM) | 2.003M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.26 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -71.76M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -2.52K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 227.58M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 103.17 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 1.056 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | -17.17M |
| Return on Equity (TTM) | Upgrade |
View All ADVM News
ADVM News
-
WireHeadlineTime (ET)
-
SA Breaking News02/15 11:17
-
Yahoo02/13 16:10
-
Globe Newswire02/11 08:30
-
SA Breaking News02/07 12:05
-
Globe Newswire01/30 07:30
-
SA Breaking News01/22 11:00
-
MT Newswires01/07 09:56
-
Globe Newswire01/06 20:00
-
Globe Newswire12/20 08:30
-
Yahoo12/12 04:32
View All Events
ADVM Events
| Date | Type | Description |
|---|---|---|
| 03/06/2019 | Earnings | Adverum Biotechnologies Inc Fourth Quarter Earnings Results in 2018 |
| 11/08/2018 | Earnings | Adverum Biotechnologies Inc Third Quarter Earnings Results in 2018 |
| 08/08/2018 | Earnings | Adverum Biotechnologies Inc Second Quarter Earnings Results in 2018 |
| 05/09/2018 | Earnings | Adverum Biotechnologies Inc First Quarter Earnings Results in 2018 |
| 03/06/2018 | Earnings | Adverum Biotechnologies Inc Fourth Quarter Earnings Results in 2017 |
ADVM Fundamentals
Income Statement View Statement
ADVM Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
ADVM One Page Reports
- One Page Report Download
ADVM Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 3.62 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.adverum.com
- Investor Relations URL: http://investors.avalanchebiotech.com/phoenix.zhtml?c=253634&p=irol-irhome
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Value
- Next Earnings Release: Mar. 06, 2019
- Last Earnings Release: Nov. 08, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Adverum Biotechnologies Inc is a US-based clinical-stage gene therapy company. The company is committed to discovering and developing novel medicines that can offer potentially life-changing therapeutic benefit to patients living with rare diseases or diseases of the eye, who currently have limited or burdensome treatment options. Its services are focused on advancing three lead gene therapy programs to address unmet needs in wet age-related macular degeneration and in rare diseases alpha-1 antitrypsin deficiency and hereditary angioedema. Its leading programs include ADVM-022, ADVM-043 and ADVM-053.
ADVM Excel Add-In Codes
- Name: =YCI("ADVM","name")
- Description: =YCI("ADVM","description")
- Sector: =YCI("ADVM","sector")
- Industry: =YCI("ADVM","industry")
- Est. Current Fiscal Year End: =YCI("ADVM","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other ADVM Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ADVM Tweets Stocktwits
Advertisement
